An Act To Save Lives through Epinephrine Autoinjector Accessibility
Maine Legislature, Session 129, LD 0641
Committee: Health Coverage, Insurance and Financial Services
Sponsors: BELLOWS, ACKLEY, CARPENTER, CLAXTON, HERBIG, MIRAMANT, FAY, HARNETT, HICKMAN, MAXMIN
Amends: 22 MRSA §2150-F, 22 MRSA §2150-G, 22 MRSA §2150-H, 32 MRSA §13815

Legislative Document
No. 641
S.P. 203
In Senate, February 7, 2019
An Act To Save Lives through Epinephrine Autoinjector 
Accessibility
Reference to the Committee on Health Coverage, Insurance and Financial Services 
suggested and ordered printed.
DAREK M. GRANT
Secretary of the Senate
Presented by Senator BELLOWS of Kennebec.
Cosponsored by Representative ACKLEY of Monmouth and
Senators: CARPENTER of Aroostook, CLAXTON of Androscoggin, HERBIG of Waldo, 
MIRAMANT of Knox, Representatives: FAY of Raymond, HARNETT of Gardiner, 
HICKMAN of Winthrop, MAXMIN of Nobleboro.
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  22 MRSA §2150-F, sub-§5 is enacted to read:
5.  Pharmacist.  "Pharmacist" has the same meaning as in Title 32, section 13702-A, 
subsection 22.
Sec. 2.  22 MRSA §2150-G, sub-§1-A is enacted to read:
1-A.  Prescribing epinephrine autoinjectors permitted.  A pharmacist may 
prescribe and dispense epinephrine autoinjectors at no cost to:
A.  A person of any age who the pharmacist reasonably believes is at risk of severe 
allergic reactions, including anaphylaxis; and
B.  A person of any age who the pharmacist reasonably believes is in a position to 
assist a person at risk of severe allergic reactions, including anaphylaxis.
Sec. 3.  22 MRSA §2150-G, sub-§5, ¶¶D and E, as enacted by PL 2015, c. 231, 
§1, are amended to read:
D.  An employee or agent of an authorized entity who has completed the training 
required by subsection 4 who provides an epinephrine autoinjector to a person 
pursuant to subsection 3, paragraph A or who administers an epinephrine autoinjector 
to a person in accordance with subsection 3, paragraph B; and
E.  An individual or entity that conducts training in accordance with subsection 4.; 
and
Sec. 4.  22 MRSA §2150-G, sub-§5, ¶F is enacted to read:
F.  A pharmacist that prescribes and dispenses epinephrine autoinjectors in 
accordance with subsection 1-A.
Sec. 5.  22 MRSA §2150-H is enacted to read:
§2150-H.  Epinephrine Autoinjector Fund
1.  Fund established.  The Epinephrine Autoinjector Fund, referred to in this section 
as "the fund," is established as a nonlapsing fund in the department for the purposes 
specified in this section.
2.  Source of funds.  The State Controller shall credit to the fund any funds 
appropriated or allocated to the fund.
3.  Uses of fund.  The fund must be used for expenses of the department to reimburse 
a pharmacist who has prescribed and dispensed an epinephrine autoinjector pursuant to 
section 2150-G, subsection 1-A.
4.  Rulemaking.  The department shall adopt rules to implement this section.  Rules 
adopted pursuant to this subsection are routine technical rules as defined in Title 5, 
chapter 375, subchapter 2-A.
Sec. 6.  32 MRSA §13815, sub-§3 is enacted to read:
3.  Rules for prescribing and dispensing epinephrine autoinjector.  The board by 
rule shall establish standards for authorizing pharmacists to prescribe and dispense an 
epinephrine autoinjector in accordance with Title 22, section 2150-G, subsection 1-A.  
The rules must establish adequate training requirements and protocols for prescribing and 
dispensing an epinephrine autoinjector when there is no prescription drug order, standing 
order or collaborative practice agreement authorizing an epinephrine autoinjector to be 
dispensed to the intended recipient.  Rules adopted under this subsection are routine 
technical rules as defined in Title 5, chapter 375, subchapter 2-A.  A pharmacist 
authorized by the board pursuant to this subsection to prescribe and dispense an 
epinephrine autoinjector may prescribe and dispense an epinephrine autoinjector in 
accordance with Title 22, section 2150-G, subsection 1-A.
Sec. 7.  Maine Revised Statutes headnote amended; revision clause.  In the 
Maine Revised Statutes, Title 32, chapter 117, subchapter 11-A, in the subchapter 
headnote, the words "prescribing and dispensing of naloxone hydrochloride" are amended 
to read "prescribing and dispensing of naloxone hydrochloride and epinephrine 
autoinjectors" and the Revisor of Statutes shall implement this revision when updating, 
publishing or republishing the statutes.
SUMMARY
This bill authorizes pharmacists to prescribe and dispense epinephrine autoinjectors 
at no cost to a person of any age who the pharmacist reasonably believes is at risk of 
experiencing severe allergic reactions, including anaphylaxis, or to a person who is in a 
position to assist the other person if the other person is at risk of experiencing severe 
allergic reactions, including anaphylaxis.  It creates a fund within the Department of 
Health and Human Services to reimburse a pharmacist who has prescribed and dispensed 
an epinephrine autoinjector and directs the department to adopt routine technical rules to 
implement the fund.